Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis

• Status: Completed
• Trial end date: 2018-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy and safety of platelet rich plasma (PRP) in patients with coxarthrosis who don´t respond to treatment with NSAIDs, compared to treatment with hyaluronic acid (Hylan G-F 20).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundación Pública Andaluza Progreso y Salud
• Treatments: Hyaluronic Acid; Hylan

Criteria

Inclusion Criteria:

• Patients> 30 years.

• Patients who voluntarily express their intention to participate by informed consent.

• Diagnosis of coxarthrosis who have failed conservative treatments for 6 months

• Women of childbearing potential must have a negative pregnancy test during screening and must agree to use adequate contraception (or two contraceptive methods, of which one is barrier) while participating in the trial.

Exclusion Criteria:

• Treatment with infiltrations 3 months prior to the study

• Prior treatment with NSAIDs 24h prior to extraction

• Pre-Surgical Treatment of Hip affects

• Diabetics

• Severe liver or kidney disease at the time of extraction

• Thrombocytopenia (<100,000 platelets / ml) at baseline

• Anemia (Hb 9- Hyaluronic acid Allergy

• History crystal arthropathy, inflammatory arthritis or neuropathic arthropathy.

• Acetabular protrusions

• History of infectious arthritis

• Excessive deformity (acetabular dysplasia, Perthes)